Cash Flow Statement
Growth Metrics

SRx Health Solutions (SRXH) Gains from Investment Securities (2017 - 2025)

SRx Health Solutions' Gains from Investment Securities history spans 8 years, with the latest figure at $39732.0 for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 96.92% year-over-year to $39732.0; the TTM value through Sep 2025 reached $39732.0, down 96.92%, while the annual FY2025 figure was $39732.0, N/A changed from the prior year.
  • Gains from Investment Securities reached $39732.0 in Q3 2025 per SRXH's latest filing, up from $34091.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $23.5 million in Q4 2021 to a low of -$29.4 million in Q2 2021.
  • Average Gains from Investment Securities over 5 years is -$259836.5, with a median of $34091.0 recorded in 2025.
  • Peak YoY movement for Gains from Investment Securities: plummeted 945.02% in 2021, then surged 28310.25% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $23.5 million in 2021, then crashed by 99.41% to $139000.0 in 2022, then soared by 65.47% to $230000.0 in 2023, then tumbled by 116.96% to -$39000.0 in 2024, then skyrocketed by 201.88% to $39732.0 in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Gains from Investment Securities are $39732.0 (Q3 2025), $34091.0 (Q2 2025), and $97854.0 (Q1 2025).